Showing results (2031-2040 of 10,388) with videos related to

Sort By:
Pageof 1,039
Vaccines|November 25, 2023
Lessons Learned from the COVID-19 Vaccination Campaigns in Veneto Region: Population Vaccination Centers as Support for the Traditional Outpatient ModelSandro Cinquetti, Anna De Polo, Vincenzo Marcotrigiano, et al.
Vaccines|November 25, 2023
Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail PharmacyManuela Di Fusco, Xiaowu Sun, Laura Anatale-Tardiff, et al.
Vaccines|November 25, 2023
Revisiting Vaccine Hesitancy in Residential Care Homes for the Elderly for Pandemic Preparedness: A Lesson from COVID-19Cyrus Lap Kwan Leung, Wan In Wei, Kin-Kit Li, et al.
Vaccines|November 25, 2023
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein MicroarraysHiroaki Saito, Hiroki Yoshimura, Makoto Yoshida, et al.
Vaccines|November 25, 2023
COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation-A Single-Center StudyLina Souan, Hikmat Abdel-Razeq, Sura Nashwan, et al.
Vaccines|November 25, 2023
Humoral and Cellular Immunity Are Significantly Affected in Renal Transplant Recipients, following Vaccination with BNT162b2Asimina Fylaktou, Stamatia Stai, Efstratios Kasimatis, et al.
Vaccines|November 25, 2023
Effects of High-Biotin Sample Interference on Antibody Concentrations in Sandwich ImmunoassaysGeraldo Balieiro Neto, Jair Rodini Engracia Filho, Fabio Enrique Lemos Budino, et al.
Vaccines|November 25, 2023
Factors Associated with COVID-19 Vaccination Promptness after Eligibility in a North Carolina Longitudinal Cohort StudyCoralei E Neighbors, Richard A Faldowski, Carl F Pieper, et al.
Vaccines|November 25, 2023
Report of the Influenza Vaccination Program in Mexico (2006-2022) and Proposals for Its ImprovementRodrigo Romero-Feregrino, Raúl Romero-Cabello, Mario Alfredo Rodríguez-León, et al.
Vaccines|November 25, 2023
Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman PrimatesMayanka Awasthi, Anthony Macaluso, Dawn Myscofski, et al.
Pageof 1,039